Nature Communications (Oct 2021)
De novo biosynthesis of bioactive isoflavonoids by engineered yeast cell factories
Abstract
Isoflavonoids are a class of industrially important plant natural products, but their low abundance and structural complexity limits their availability. Here, the authors engineer Saccharomyces cerevisiae metabolism to become a platform for efficient production of daidzein which is core chemical scaffold for isoflavonoid biosynthesis, and show its application for production of bioactive glucosides from glucose.